These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27516474)

  • 1. Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
    Petitcollin A; Dequin PF; Darrouzain F; Vecellio L; Boulain T; Garot D; Paintaud G; Ternant D; Ehrmann S
    J Antimicrob Chemother; 2016 Dec; 71(12):3482-3486. PubMed ID: 27516474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Yang J; Liu Z; Gutierrez C; Aymard G; Rouby JJ;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):106-15. PubMed ID: 21474643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
    Boisson M; Grégoire N; Cormier M; Gobin P; Marchand S; Couet W; Mimoz O
    J Antimicrob Chemother; 2017 Sep; 72(9):2607-2612. PubMed ID: 28575278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure.
    Luyt CE; Eldon MA; Stass H; Gribben D; Corkery K; Chastre J
    J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):183-90. PubMed ID: 21361783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects.
    Ehrmann S; Mercier E; Vecellio L; Ternant D; Paintaud G; Dequin PF
    Intensive Care Med; 2008 Apr; 34(4):755-62. PubMed ID: 18046534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients.
    Montgomery AB; Vallance S; Abuan T; Tservistas M; Davies A
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):441-8. PubMed ID: 24383962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.
    Burdet C; Pajot O; Couffignal C; Armand-Lefèvre L; Foucrier A; Laouénan C; Wolff M; Massias L; Mentré F
    Eur J Clin Pharmacol; 2015 Jan; 71(1):75-83. PubMed ID: 25327505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.
    De Winter S; van Hest R; Dreesen E; Annaert P; Wauters J; Meersseman W; Van den Eede N; Desmet S; Verelst S; Vanbrabant P; Peetermans W; Spriet I
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):653-663. PubMed ID: 34297338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of once-daily amikacin dose in critically ill adults.
    Šíma M; Hartinger J; Cikánková T; Slanař O
    J Chemother; 2018 Feb; 30(1):37-43. PubMed ID: 28950787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
    Benítez-Cano A; de Antonio-Cuscó M; Luque S; Sorlí L; Carazo J; Ramos I; Bermejo S; Campillo N; Horcajada JP; Samsó E; Grau S
    J Antimicrob Chemother; 2019 Nov; 74(11):3268-3273. PubMed ID: 31495877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia.
    Najmeddin F; Shahrami B; Azadbakht S; Dianatkhah M; Rouini MR; Najafi A; Ahmadi A; Sharifnia H; Mojtahedzadeh M
    J Intensive Care Med; 2020 Apr; 35(4):400-404. PubMed ID: 29471721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients.
    Boisson M; Mimoz O; Hadzic M; Marchand S; Adier C; Couet W; Grégoire N
    J Antimicrob Chemother; 2018 Oct; 73(10):2830-2837. PubMed ID: 29947799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs.
    Goldstein I; Wallet F; Robert J; Becquemin MH; Marquette CH; Rouby JJ
    Am J Respir Crit Care Med; 2002 Jan; 165(2):171-5. PubMed ID: 11790649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.
    Marsot A; Guilhaumou R; Riff C; Blin O
    Clin Pharmacokinet; 2017 Feb; 56(2):127-138. PubMed ID: 27324191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.
    D'Arcy DM; Casey E; Gowing CM; Donnelly MB; Corrigan OI
    BMC Pharmacol Toxicol; 2012 Nov; 13():14. PubMed ID: 23136834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tolerability of BAY41-6551 in subjects with chronic kidney disease.
    Stass H; Corkery K; Gribben D; Eldon MA
    J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):191-9. PubMed ID: 21599533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis.
    Roger C; Nucci B; Louart B; Friggeri A; Knani H; Evrard A; Lavigne JP; Allaouchiche B; Lefrant JY; Roberts JA; Muller L
    J Antimicrob Chemother; 2016 Jan; 71(1):208-12. PubMed ID: 26429564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
    Lugo G; Castañeda-Hernández G
    Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.